Ai Antibody Drug Conjugates

Antibody Discovery Platforms

Doctoral research examines display, immunisation and single cell routes to isolating binding molecules. Discovery platform choice determines the diversity and quality of candidates entering a programme.

Antibody Humanisation Strategies

Research investigates conversion of animal derived binders into forms tolerated by the human immune system. Humanisation must preserve binding while removing sequences that provoke immune response.

Fully Human Antibody Generation

Doctoral study addresses systems producing human sequence binders without a humanisation step. Avoiding humanisation removes a common source of affinity loss.

Machine Learning For Antibody Design

Research examines learned models proposing sequences with desired binding and biophysical properties. Computational design compresses cycles that experimental screening performs slowly.

Structure Based Antibody Engineering

Doctoral work studies rational sequence change guided by three dimensional binding models. Structural reasoning explains why particular substitutions succeed or fail.

Affinity Maturation Methods

Research investigates iterative improvement of binding strength through selection and design. Affinity influences tumour uptake, penetration and normal tissue exposure together.

Epitope Mapping And Selection

Doctoral study addresses identification of the precise region bound on a target molecule. Epitope choice governs internalisation, competition and functional consequence of binding.

Antibody Format Engineering

Research examines molecular architectures beyond conventional immunoglobulin structure. Format determines size, valency, half life and tissue penetration.

Bispecific Scaffolds For Conjugates

Doctoral work studies binders engaging two targets and their use as delivery vehicles. Dual engagement can improve selectivity where no single target is tumour restricted.

Antibody Fragment Conjugates

Research investigates smaller binding fragments as carriers for cytotoxic cargo. Reduced size improves penetration but shortens circulation time substantially.

Single Domain Binder Carriers

Doctoral study addresses very small single domain binders as delivery scaffolds. Their stability and size open tissue compartments larger molecules cannot reach.

Non Antibody Protein Scaffolds

Research examines engineered binding proteins derived from other structural families. These scaffolds offer manufacturing and format advantages over immunoglobulins.

Peptide Drug Conjugates

Doctoral work studies peptides as targeting elements carrying cytotoxic cargo. Peptides penetrate tissue rapidly but are cleared and degraded quickly.

Small Molecule Drug Conjugates

Research investigates non protein targeting ligands delivering cytotoxic payloads. Small ligands avoid immunogenicity and permit chemical synthesis of the entire construct.

Fc Engineering For Conjugates

Doctoral study addresses modification of the constant region governing half life and immune engagement. Fc properties shape both exposure and unintended cellular uptake.

Contribution Of Effector Function

Research examines whether immune effector mechanisms contribute to conjugate efficacy. The question determines whether effector function should be preserved or removed.

Antibody Stability Engineering

Doctoral work studies sequence and structural features governing thermal and chemical robustness. Stability determines manufacturability and shelf life of the finished product.

Prediction Of Aggregation Propensity

Research investigates computational forecasting of self association behaviour. Aggregation causes both manufacturing failure and immune reactions in patients.

Developability Assessment

Doctoral study addresses early evaluation of properties predicting successful development. Early assessment prevents investment in candidates that will fail later on biophysics.

Immunogenicity Prediction

Research examines computational and experimental forecasting of immune response to a candidate. Immune response against the construct removes both efficacy and safety.

Glycosylation Engineering

Doctoral work studies control of attached sugar structures and their functional consequences. Glycan structure influences clearance, effector engagement and immune recognition.

Isotype Selection For Conjugates

Research investigates choice among constant region classes for cytotoxic delivery. Isotype governs half life, effector engagement and unintended uptake pathways.

Antibody Internalisation Kinetics

Doctoral study addresses the rate and extent of cellular uptake after binding. Internalisation rate is frequently more predictive of activity than binding affinity.

Intracellular Trafficking Of Conjugates

Research examines routing through endosomal and lysosomal compartments after uptake. Trafficking route determines whether payload is released or recycled without effect.

Sequence Liability Analysis

Doctoral work studies motifs prone to chemical degradation during manufacture and storage. Liability removal early prevents instability discovered at costly later stages.

Target Antigen Identification

Research investigates discovery of molecules suitable as delivery targets. Target choice is the single most consequential decision in a conjugate programme.

Target Expression Profiling In Tumours

Doctoral study addresses quantitative measurement of target abundance across patient samples. Expression distribution determines what fraction of patients could benefit.

Normal Tissue Expression Assessment

Research examines target presence in healthy tissues and the toxicity this implies. Normal expression is the principal predictor of dose limiting harm.

Requirements For Target Internalisation

Doctoral work studies how uptake behaviour of a target constrains conjugate design. Poorly internalising targets require entirely different release strategies.

Strategies For Non Internalising Targets

Research investigates payload release outside the cell for targets that remain on the surface. Extracellular release approaches expand the accessible target space considerably.

Targets Within The Tumour Microenvironment

Doctoral study addresses delivery to non malignant components of tumour tissue. Microenvironment targeting can affect tumours whose own antigens are heterogeneous.

Stromal And Vascular Targeting

Research examines delivery directed at supporting tissue and blood vessels. Vascular targets are accessible without requiring penetration into tumour mass.

Immune Cell Directed Conjugates

Doctoral work studies delivery of cargo to immune populations rather than tumour cells. Immune directed delivery aims to reshape response rather than kill directly.

Antigen Heterogeneity Within Tumours

Research investigates variation in target expression between cells of one tumour. Heterogeneity limits efficacy and drives selection of non expressing populations.

Target Density Thresholds

Doctoral study addresses how much target is required for meaningful payload delivery. Threshold understanding defines which patients should be selected for treatment.

Antigen Shedding And Soluble Target

Research examines circulating target fragments intercepting the conjugate before it reaches tumour. Soluble target acts as a sink that consumes administered dose.

Target Validation Methodologies

Doctoral work studies experimental evidence establishing a target as suitable and dependable. Validation rigour determines how many programmes fail at clinical stage.

Single Cell Analysis Of Target Expression

Research investigates target abundance measured cell by cell rather than in bulk. Single cell measurement reveals heterogeneity that bulk assays average away.

Spatial Profiling Of Target Distribution

Doctoral study addresses where within tissue architecture the target is located. Spatial context determines whether a target is physically reachable.

Computational Target Prioritisation

Research examines algorithmic ranking of candidate targets using multiple evidence types. Systematic prioritisation replaces target selection driven by familiarity.

Target Discovery From Omic Datasets

Doctoral work studies mining of expression, protein and genomic resources for candidates. Public datasets contain far more candidate evidence than has been exploited.

Cross Species Target Conservation

Research investigates whether targets are shared with species used in safety testing. Conservation determines whether preclinical toxicology is informative at all.

Targets In Haematological Malignancy

Doctoral study addresses delivery targets on blood and lymphoid cancer cells. Blood cancers offer accessible targets and were the earliest clinical successes.

Target Selection In Solid Tumours

Research examines the distinct constraints targets face in solid tissue. Penetration, pressure and heterogeneity all complicate solid tumour delivery.

Targets In Rare Cancers

Doctoral work studies delivery opportunities in cancers with small patient populations. Rare disease programmes face different evidence and commercial constraints.

Non Oncology Target Selection

Research investigates targeted cytotoxic and modulatory delivery outside cancer. Non oncology applications demand far higher safety margins.

Autoimmune Disease Targeting

Doctoral study addresses selective removal or modulation of pathogenic immune cells. Selective approaches aim to avoid broad immune suppression.

Conjugate Targets In Infectious Disease

Research examines delivery of antimicrobial cargo to infected cells or organisms. Targeted delivery could restore activity of agents limited by toxicity.

Access To Neurological Targets

Doctoral work studies delivery across the barrier protecting the central nervous system. Barrier crossing remains the principal obstacle to neurological application.

Target Related Resistance Mechanisms

Research investigates loss or modification of target expression under treatment pressure. Target loss is a recurring cause of acquired resistance.

Microtubule Targeting Payloads

Doctoral study addresses cytotoxic agents disrupting cell division through microtubule interference. This payload class dominated early conjugate development.

Topoisomerase Inhibitor Payloads

Research examines payloads interfering with enzymes managing chromosome topology. This class produced several recent clinical successes with distinctive properties.

Payloads Causing Direct Genomic Damage

Doctoral work studies highly potent agents damaging chromosomal material directly. Extreme potency permits activity at very low delivered amounts.

Transcription Inhibiting Payloads

Research investigates payloads blocking synthesis of messenger molecules within targeted cells. This mechanism affects cells regardless of their division state, unlike most established payload classes.

Payload Potency Optimisation

Doctoral study addresses tuning of cytotoxic strength to the delivery achievable. Excessive potency amplifies the consequences of any off target delivery.

Bystander Effect Mechanisms

Research examines killing of neighbouring cells by payload escaping the targeted cell. Bystander activity addresses heterogeneity but reduces selectivity.

Payload Membrane Permeability

Doctoral work studies whether released payload can cross cell membranes. Permeability determines both bystander activity and unintended systemic exposure.

Discovery Of New Payload Classes

Research investigates cytotoxic mechanisms not yet exploited in targeted delivery. New mechanisms address resistance to established payload classes.

Immunomodulatory Payloads

Doctoral study addresses delivery of agents stimulating immune response rather than killing cells. Targeted immune stimulation aims to concentrate activity within tumours.

Protein Degrader Payloads

Research examines cargo that directs specific proteins for cellular destruction. Degrader payloads act catalytically and reach targets conventional inhibitors cannot.

Nucleic Acid Payloads

Doctoral work studies delivery of regulatory or genetic material to targeted cells. Nucleic acid cargo faces distinctive stability and release challenges.

Radionuclide Conjugates

Research investigates delivery of radioactive isotopes for therapy and imaging. Radiation acts over distance and does not require internalisation.

Enzyme Payload Conjugates

Doctoral study addresses delivery of catalytically active proteins to target cells. Enzymatic cargo can generate active agents locally from inert precursors.

Photosensitiser Conjugates

Research examines cargo activated by light delivered to a defined region. Light dependence adds a second layer of spatial control over activity.

Dual Payload Conjugates

Doctoral work studies constructs carrying two distinct cytotoxic mechanisms. Combined mechanisms aim to prevent resistance emerging to either alone.

Payload Related Resistance Mechanisms

Research investigates cellular adaptations reducing sensitivity to the delivered agent. Payload resistance persists even where targeting remains effective.

Interaction With Efflux Transporters

Doctoral study addresses cellular pumps removing payload before it acts. Efflux is a major and predictable route to resistance for several payload classes.

Payload Metabolism And Catabolite Formation

Research examines chemical processing of payload and the species subsequently produced. Catabolite properties determine systemic exposure and bystander behaviour.

Structure Activity Relationship Modelling

Doctoral work studies systematic relationships between payload structure and biological activity. Modelling guides synthesis toward regions of chemical space worth exploring.

Computational Payload Design

Research investigates machine assisted proposal of cytotoxic molecules with defined properties. Computational design targets the slow synthesis and testing cycle.

Payload Toxicity Profiling

Doctoral study addresses the intrinsic toxicity signature of a payload independent of targeting. Payload class largely predicts the toxicities patients will experience.

Selection Of Payload Mechanism

Research examines matching payload mechanism to tumour biology and patient population. Mechanism choice determines which tumours can plausibly respond.

Management Of Payload Water Solubility

Doctoral work studies aggregation and rapid clearance caused by poorly water soluble payloads. Solubility behaviour limits how many payload molecules can be attached to a single binder.

Cell Cycle Dependence Of Payload Activity

Research investigates whether payload requires actively dividing cells to act. Cycle dependence limits activity against slowly proliferating tumours.

Payload Activity In Quiescent Cells

Doctoral study addresses killing of non dividing tumour cell populations. Quiescent cells survive most cytotoxic treatment and seed later relapse.

Cleavable Linker Chemistry

Research examines chemical connections designed to break under defined biological conditions. Cleavable systems permit payload release in free and active form.

Non Cleavable Linker Design

Doctoral work studies stable connections requiring protein degradation for payload release. Stable linkers reduce circulating free payload at the cost of release flexibility.

Protease Sensitive Linkers

Research investigates connections severed by enzymes concentrated in target compartments. Enzymatic specificity provides a biological trigger for release.

Acid Labile Linker Systems

Doctoral study addresses connections responding to the acidity of intracellular compartments. Acid sensitivity exploits a reliable difference between compartments.

Reducible Linker Chemistry

Research examines connections severed by the reducing conditions inside cells. Redox differences between inside and outside provide a release trigger.

Glycosidase Cleavable Linkers

Doctoral work studies sugar based connections cleaved by specific enzymes. These systems combine high circulating stability with efficient intracellular release.

Linker Stability In Circulation

Research investigates premature severing of the connection while in the bloodstream. Circulating stability is the principal determinant of systemic toxicity.

Premature Payload Release

Doctoral study addresses mechanisms and consequences of cargo liberated before reaching target. Early release converts a targeted agent into an untargeted one.

Water Compatible Linker Design

Research examines connection chemistry that offsets the poor water solubility of potent payloads. Such linkers permit higher payload loading without triggering aggregation or accelerated clearance.

Linker Length And Spacer Effects

Doctoral work studies geometric separation between binder and payload. Spacing influences release efficiency, binding and biophysical behaviour.

Traceless Release Mechanisms

Research investigates chemistry liberating payload with no residual attachment. Residue free release preserves the native potency of the payload.

Computational Linker Design

Doctoral study addresses simulation guided design of connection chemistry. Computational approaches reduce the empirical screening linker development requires.

Linker And Payload Interaction Effects

Research examines how connection chemistry modifies payload behaviour and properties. Linker and payload cannot be optimised independently of one another.

Tumour Selective Activation

Doctoral work studies constructs becoming active only under tumour specific conditions. Conditional activation widens the therapeutic window substantially.

Conditionally Active Conjugates

Research investigates binders masked until unmasked within target tissue. Masking strategies aim to prevent binding to healthy tissue entirely.

Cysteine Based Conjugation

Doctoral study addresses attachment through reduced sulphur containing residues. Cysteine chemistry produces defined but structurally destabilising attachment.

Lysine Based Conjugation

Research examines attachment through amine containing residues distributed across the protein. This approach is simple but yields heterogeneous product mixtures.

Site Specific Conjugation Methods

Doctoral work studies attachment at defined positions producing uniform products. Uniformity improves both consistency and therapeutic window.

Enzymatic Conjugation Approaches

Research investigates enzymes catalysing attachment at defined recognition sequences. Enzymatic methods achieve specificity under gentle reaction conditions.

Incorporation Of Unnatural Amino Acids

Doctoral study addresses engineered residues providing unique attachment chemistry. Engineered residues permit chemistry orthogonal to natural protein groups.

Glycan Based Conjugation

Research examines attachment through engineered or natural sugar structures. Glycan attachment sites are distant from binding regions by design.

Bridging Conjugation Chemistry

Doctoral work studies reagents spanning both partners of a reduced disulphide bond. Bridging preserves structural integrity that simple reduction compromises.

Control Of Drug To Antibody Ratio

Research investigates the number of payload molecules attached per binder. This ratio governs potency, clearance and aggregation simultaneously.

Homogeneity Of Conjugate Species

Doctoral study addresses the distribution of species within a conjugate preparation. Heterogeneous mixtures behave as several distinct agents administered together.

Effects Of Conjugation Site On Function

Research examines how attachment position affects binding, stability and release. Site effects are large and frequently unpredictable without experiment.

Bioorthogonal Chemistry Applications

Doctoral work studies reactions proceeding selectively in complex biological mixtures. Orthogonal chemistry enables attachment without protecting group strategies.

Assembly Within The Body

Research investigates constructs assembled after administration rather than before. In place assembly could separate delivery of targeting and payload components.

Conjugation Process Optimisation

Doctoral study addresses reaction conditions maximising yield and consistency. Process robustness determines whether laboratory chemistry survives manufacturing scale.

Scale Up Of Conjugation Chemistry

Research examines translation of small scale reactions to production volumes. Scale changes mixing, heat transfer and exposure control fundamentally.

Reaction Monitoring And Control

Doctoral work studies real time measurement guiding conjugation reactions. In process measurement replaces reliance on end point testing alone.

Analytical Characterisation Of Conjugates

Research investigates the analytical package describing a heterogeneous protein chemical hybrid. Characterisation demands span both protein and small molecule analysis.

Mass Spectrometry Of Conjugates

Doctoral study addresses mass based determination of attachment number and position. Mass analysis is the primary tool for defining conjugate composition.

Chromatographic Separation Methods

Research examines separation of species differing in payload number and attachment site. Separation quality determines what heterogeneity can be measured at all.

Determination Of Drug Load Distribution

Doctoral work studies quantification of the full distribution of loading states. Distribution rather than average load governs biological behaviour.

Quantification Of Unattached Payload

Research investigates measurement of free cytotoxic material in preparations and plasma. Free payload is a direct contributor to systemic toxicity.

Higher Order Structure Analysis

Doctoral study addresses measurement of folding and assembly state after conjugation. Chemistry can disturb structure in ways binding assays do not reveal.

Stability And Forced Degradation Studies

Research examines behaviour under stress conditions to identify degradation routes. Degradation knowledge defines formulation and storage requirements.

Formulation Development

Doctoral work studies excipients and conditions maintaining conjugate integrity. Formulation must stabilise both protein and attached chemical simultaneously.

Freeze Drying And Storage

Research investigates dried presentations and their effect on conjugate integrity. Dried formats extend shelf life and simplify distribution requirements.

Aggregation Control In Formulation

Doctoral study addresses prevention of self association during storage and handling. Aggregates carry both efficacy loss and immunogenicity risk.

Comparability Assessment

Research examines demonstration that material remains equivalent after process changes. Comparability evidence determines whether new material requires new clinical data.

Reference Standard Establishment

Doctoral work studies preparation and qualification of materials anchoring analytical measurement. Reference standards make results comparable across time and sites.

Process Analytical Technology

Research investigates measurement embedded within manufacturing rather than after it. In process measurement supports control rather than retrospective judgement.

Manufacturing Process Development

Doctoral study addresses design of robust reproducible production processes. Process design determines both product quality and cost of supply.

Cell Line Development For Antibodies

Research examines generation of producing cell lines with high yield and stability. Cell line quality governs the economics of the entire supply chain.

Upstream Bioprocess Optimisation

Doctoral work studies culture conditions maximising quantity and quality of produced protein. Upstream conditions influence glycosylation and impurity content directly.

Downstream Purification Strategy

Research investigates separation of product from process related impurities. Purification must handle both biological and chemical contaminants.

Continuous Manufacturing Approaches

Doctoral study addresses uninterrupted rather than batch based production. Continuous operation offers consistency and reduced facility footprint.

Quality By Design In Conjugate Manufacture

Research examines systematic linkage of process parameters to product attributes. This framework replaces empirical process fixing with designed understanding.

Impurity Profiling And Control

Doctoral work studies identification and limitation of unwanted species in product. Impurity control is complicated by the hybrid nature of these molecules.

Containment For Cytotoxic Handling

Research investigates facility and equipment design protecting operators from potent compounds. Containment requirements shape facility cost and site selection.

Supply Chain For Conjugate Components

Doctoral study addresses sourcing and coordination of antibody, linker and payload supply. Multi component supply chains multiply points of potential failure.

Cost Of Goods Modelling

Research examines the economic structure of conjugate manufacture. Production economics influence which indications and markets are addressable.

Machine Learning In Bioprocess Control

Doctoral work studies learned models predicting and controlling production processes. Predictive control targets batch to batch variation that fixed recipes permit.

Digital Representation Of Manufacturing Processes

Research investigates synchronised virtual models of production operations. Virtual models support scenario testing without consuming production capacity.

Design Of Cytotoxicity Assays

Doctoral study addresses in vitro measurement of conjugate killing activity. Assay design determines whether measured potency predicts anything in vivo.

Cell Line Panel Screening

Research examines activity profiling across diverse tumour derived cell lines. Panel screening links activity to molecular features of responding cells.

Patient Derived Model Systems

Doctoral work studies models established directly from patient tumour material. Patient derived systems retain heterogeneity that established lines have lost.

Organoid Models For Conjugate Testing

Research investigates three dimensional cultures preserving tissue architecture. Architecture affects penetration and therefore measured activity.

Three Dimensional Culture Models

Doctoral study addresses spheroid and matrix based systems reproducing tissue barriers. Flat culture systematically overestimates conjugate potency.

Microphysiological Systems

Research examines engineered devices reproducing tissue and vascular interaction. These systems permit study of delivery barriers outside animals.

Xenograft Model Selection

Doctoral work studies choice of implanted human tumour models for efficacy testing. Model choice strongly determines whether efficacy is observed.

Immunocompetent Animal Models

Research investigates models retaining a functional immune system for conjugate evaluation. Immune competence matters for immunomodulatory and effector dependent designs.

Pharmacokinetic Characterisation

Doctoral study addresses circulating concentration and clearance of conjugate species over time. Multiple analytes must be tracked because the construct changes in circulation.

Bioanalysis Of Conjugate Species

Research examines assays distinguishing intact conjugate, free binder and released payload. Analyte definition determines what pharmacokinetic conclusions can be reached.

Pharmacokinetic And Pharmacodynamic Modelling

Doctoral work studies quantitative linkage between exposure and biological effect. These models support dose selection before clinical testing begins.

Physiologically Based Modelling Of Conjugates

Research investigates mechanistic models representing tissue distribution and binding. Mechanistic models extrapolate across species and dose regimens.

Tumour Penetration And Distribution

Doctoral study addresses how far constructs travel into tumour tissue from vessels. Penetration limits mean many tumour cells never encounter the agent.

Binding Site Barrier Effects

Research examines how high affinity binding near vessels prevents deeper distribution. This effect creates a counterintuitive penalty for stronger binding.

Imaging Of Conjugate Biodistribution

Doctoral work studies labelled constructs visualised within living subjects. Imaging reveals distribution that tissue sampling can only approximate.

Dose Fractionation Studies

Research investigates splitting administration across time to improve tolerability. Fractionation can separate efficacy from toxicity where kinetics differ.

Preclinical To Clinical Translation

Doctoral study addresses why preclinical activity frequently fails to predict clinical outcome. Translation failure is the dominant source of programme attrition.

Species Differences In Tolerability

Research examines why toxicity profiles differ between test species and humans. Species differences in target expression drive much of this divergence.

Off Target Uptake Mechanisms

Doctoral work studies cellular uptake proceeding independently of the intended target molecule. Non specific uptake explains toxicities that bear no relation to where the target is expressed.

Mechanisms Of Ocular Toxicity

Research investigates eye injury observed with several conjugate classes. Ocular effects are frequently dose limiting yet mechanistically unclear.

Mechanisms Of Peripheral Nerve Injury

Doctoral study addresses nerve damage associated with particular payload classes. Nerve injury accumulates with treatment and can be irreversible.

Mechanisms Of Lung Injury

Research examines the inflammatory interstitial lung injury reported with several conjugate classes. This toxicity is uncommon but can progress rapidly and is a recognised cause of treatment related death.

Mechanisms Of Blood Cell Toxicity

Doctoral work studies suppression of blood cell production and the mechanisms responsible for it. Reduced blood counts are among the most frequently dose limiting effects across conjugate classes.

Mechanisms Of Liver Injury

Research investigates hepatic uptake and injury following conjugate administration. Liver uptake is a common route for constructs lost from circulation.

Toxicity Prediction Modelling

Doctoral study addresses computational forecasting of adverse effects from construct properties. Prediction would move safety assessment earlier in design.

Therapeutic Index Optimisation

Research examines widening the separation between effective and toxic exposures. The therapeutic window rather than potency limits most programmes.

Immunogenicity Assessment

Doctoral work studies measurement of immune response against administered constructs. Immune response can remove exposure entirely within a few cycles.

Consequences Of Antidrug Antibodies

Research investigates clinical effects of immune recognition of the therapeutic. Consequences range from accelerated clearance to serious reactions.

Safety Biomarker Discovery

Doctoral study addresses measurable indicators predicting or detecting toxicity early. Early indicators permit intervention before injury becomes established.

Design Of Regulatory Toxicology Packages

Research examines the nonclinical safety programme required before human study. Package design determines both timeline and the questions regulators can answer.

First In Human Trial Design

Doctoral work studies starting dose, escalation and monitoring for initial clinical study. Design decisions here determine both patient safety and information yield.

Dose Optimisation Strategy

Research investigates identification of doses balancing efficacy and tolerability. Historical reliance on maximum tolerated dose is being actively reconsidered.

Exposure Response Analysis

Doctoral study addresses relationships between measured exposure and both benefit and harm. Exposure response evidence underpins rational dose selection.

Patient Selection Biomarkers

Research examines measurements identifying patients likely to benefit. Selection determines observed efficacy as much as the agent itself does.

Companion Diagnostic Development

Doctoral work studies co developed tests determining treatment eligibility. Diagnostic performance directly bounds the observed benefit of the therapeutic.

Immunohistochemical Scoring Methods

Research investigates tissue staining assessment used to measure target expression. Scoring reproducibility is a recognised weakness in patient selection.

Digital Pathology For Patient Selection

Doctoral study addresses automated image analysis of stained tissue sections. Automation targets the substantial variability between human assessors.

Circulating Biomarker Monitoring

Research examines blood measurements tracking response and resistance during treatment. Circulating measures permit monitoring without repeat tissue sampling.

Response Assessment Methods

Doctoral work studies imaging and clinical measurement of tumour response to conjugate treatment. Assessment criteria determine what counts as benefit and therefore what regulators will approve.

Resistance Emergence In Patients

Research investigates mechanisms by which tumours stop responding during treatment. Resistance mechanisms differ from those predicted by laboratory models.

Combination With Immune Checkpoint Therapy

Doctoral study addresses conjugates given alongside immune activating antibodies. Cytotoxic cell death may increase immune recognition of the tumour.

Combination With Targeted Agents

Research examines pairing with inhibitors of specific signalling pathways. Combination rationale must account for overlapping toxicity as well as efficacy.

Combination With Conventional Chemotherapy

Doctoral work studies conjugates administered with cytotoxic drug regimens. Overlapping toxicity frequently constrains these combinations severely.

Combination With Radiation Therapy

Research investigates conjugates administered alongside or sequentially with radiotherapy. Timing, radiation field and overlapping tissue injury together shape both the benefit and the toxicity observed.

Sequencing Of Therapy Lines

Doctoral study addresses where conjugates should sit within the sequence of treatments a patient receives. Prior therapy affects target expression, organ reserve and tolerance of subsequent regimens.

Management Of Adverse Effects

Research examines prevention, monitoring and treatment of conjugate toxicities. Effective management determines how long patients can remain on treatment.

Real World Outcome Evidence

Doctoral work studies outcomes in routine practice beyond trial populations. Real world populations differ substantially from those enrolled in trials.

Health Economic Evaluation

Research investigates cost effectiveness of conjugate therapies within health systems. Economic assessment determines availability irrespective of clinical benefit.

Access And Reimbursement Pathways

Doctoral study addresses routes by which approved therapies reach patients. Access decisions vary widely between health systems for identical evidence.

Diversity And Representation In Trials

Research examines whether trial populations reflect those who will receive treatment. Unrepresentative evidence produces uncertainty precisely where need is greatest.

Paediatric Development Of Conjugates

Doctoral work studies evaluation, dosing and safety monitoring of conjugates in children. Paediatric development requires separate evidence while facing very small eligible patient numbers.

Conjugates In Older Patients

Research investigates tolerability and benefit in patients with reduced organ reserve. Older patients dominate cancer incidence yet are underrepresented in trials.

Reproductive And Developmental Safety

Doctoral study addresses risks to fertility, pregnancy and offspring. Cytotoxic payloads carry inherent reproductive risk requiring careful characterisation.

Post Marketing Surveillance

Research examines systematic detection of rare harms once a therapy is in widespread clinical use. Uncommon toxicities only become visible at the exposure scale that trials cannot reach.

Regulatory Frameworks For Conjugates

Doctoral work studies how regulators evaluate these hybrid biological chemical products. Regulatory expectations span both biological and small molecule requirements.

Generative Models For Conjugate Design

Research investigates machine generation of candidate binders, linkers and payloads. Generative design searches chemical space no screening campaign could cover.

Applications Of Protein Structure Prediction

Doctoral study addresses computational structures used in conjugate design decisions. Predicted structures make structure guided design possible without experimental determination.

Molecular Simulation Of Conjugates

Research examines dynamic simulation of constructs including attached chemistry. Simulation explains behaviour that static structures cannot represent.

Quantitative Systems Pharmacology Models

Doctoral work studies mechanistic models spanning binding, distribution and cellular effect. System models integrate evidence that separate studies leave disconnected.

Multi Objective Optimisation In Design

Research investigates simultaneous balancing of potency, stability, safety and manufacturability. Conjugate design is inherently a trade off among competing requirements.

Data Integration Across Discovery Programmes

Doctoral study addresses unification of assay, structural and clinical data. Integration converts scattered programme data into a learnable resource.

Federated Learning Across Institutions

Research examines collaborative modelling without sharing proprietary datasets. Federation addresses the commercial secrecy that fragments this field.

Knowledge Graphs For Conjugate Research

Doctoral work studies structured representation of targets, payloads, linkers and outcomes. Structured knowledge supports queries the literature cannot answer directly.

Literature Mining For Target Evidence

Research investigates automated extraction of evidence from published sources. Automated mining surfaces target evidence buried across scattered publications.

Reproducibility In Conjugate Research

Doctoral study addresses whether published findings can be regenerated independently. Reproducibility problems in preclinical oncology are well documented.

Benchmark Datasets For Design Models

Research examines shared datasets enabling fair comparison of computational methods. Benchmark scarcity makes reported computational performance difficult to trust.

Intellectual Property Landscape

Doctoral work studies patent structure across binders, linkers, payloads and processes. Layered protection shapes which designs can be pursued commercially.

Follow On And Biosimilar Conjugates

Research investigates the feasibility of copies of complex hybrid products. Structural heterogeneity makes demonstration of similarity unusually demanding.

Environmental Handling Of Cytotoxic Waste

Doctoral study addresses safe disposal of highly potent manufacturing and clinical waste. Waste handling obligations extend from factory through to patient care.

Equitable Access To Advanced Therapeutics

Research examines the ethical and practical distribution of expensive targeted treatments. Access disparity is widening as therapeutic complexity increases.